抗菌肽LL-37的研究进展及其与动脉粥样硬化的关系
DOI:
作者:
作者单位:

(1.昆明医科大学,云南省昆明市 650500;2.云南大学附属医院超声科,云南省昆明市 650000)

作者简介:

邱凤娇,硕士研究生,研究方向为心血管超声,E-mail:qfengj@126.com。

通讯作者:

基金项目:

国家自然科学基金项目(82260095);云南省心血管超声创新团队(202305AS350021);云南省科技厅-昆明医科大学基础研究联合专项(202301AY070001-216)


Research progress on antimicrobial peptide LL-37 and its relationship with atherosclerosis
Author:
Affiliation:

1.Kunming Medical University, Kunming, Yunnan 650500, China;2.Department of Ultrasound, Affiliated Hospital of Yunnan University, Kunming, Yunnan 650000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    抗菌肽LL-37(LL-37)作为人类天然免疫系统的重要效应分子,兼具广谱抗菌、免疫调节和促炎/抗炎双重功能。近年来研究发现,LL-37在动脉粥样硬化(As)的发生发展中扮演复杂角色,其通过抗菌作用影响斑块微环境,调控炎症反应、氧化应激和血管平滑肌细胞(VSMC)的行为,参与斑块形成与稳定性的调节。本文系统综述LL-37的生物学特性、功能机制及其在As中的作用,以及其与线粒体DNA(mtDNA)形成的LL-37-mtDNA复合物,旨在为靶向LL-37-mtDNA复合物的治疗策略提供理论依据。

    Abstract:

    As a critical effector molecule of the human innate immune system, the antimicrobial peptide LL-37 possesses broad-spectrum antimicrobial activity, immunomodulatory effects, and dual pro-inflammatory and anti-inflammatory functions. Recent studies have revealed that LL-37 plays a complex role in the initiation and progression of atherosclerosis (As). It affects the plaque microenvironment through its antimicrobial effects, regulates inflammatory responses, oxidative stress, and the behaviors of vascular smooth muscle cells (VSMC), and participates in the modulation of plaque formation and stability. This article systematically reviews the biological characteristics and functional mechanisms of LL-37, its role in As, and the LL-37-mtDNA complex formed by LL-37 and mtDNA, aiming to provide a theoretical basis for therapeutic strategies targeting the LL-37-mtDNA complex.

    参考文献
    相似文献
    引证文献
引用本文

邱凤娇,陆永萍,杨寒凝,曹文琪,杨舒婷.抗菌肽LL-37的研究进展及其与动脉粥样硬化的关系[J].中国动脉硬化杂志,2026,34(10):1019~1025.

复制
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2025-08-07
  • 最后修改日期:2025-10-11
  • 录用日期:
  • 在线发布日期: 2026-11-19